Metabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia Patients

Published:2010-05-17 Issue:8 Volume:38 Page:1328-1340
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Gong Aishen,Chen Xiaoyan,Deng Pan,Zhong Dafang

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference13 articles.

1. MSE with mass defect filtering forin vitro andin vivo metabolite identification

2. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

3. METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS

4. Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

5. Selective reduction of N-oxides to amines: application to drug metabolism;Kulanthaivel;Drug Metab Dispos,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacokinetics and drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective;Critical Reviews in Oncology/Hematology;2024-03

2. Pharmacokinetics of single- and multiple-dose flumatinib in patients with chronic phase chronic myeloid leukemia;Frontiers in Oncology;2023-02-06

3. Developing therapeutic approaches for chronic myeloid leukemia: a review;Molecular and Cellular Biochemistry;2022-10-10

4. The progress of small-molecules and degraders against BCR-ABL for the treatment of CML;European Journal of Medicinal Chemistry;2022-08

5. Research Status, Synthesis and Clinical Application of Recently Marketed and Clinical BCR-ABL Inhibitors;Current Medicinal Chemistry;2021-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3